第 1 到 23 筆結果,共 23 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2021 | Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction | Liu H.-C.; Chen H.-H.; Ho C.-S.; Chang J.-F.; Lin C.-C.; MING-JANG CHIU ; TA-FU CHEN ; Hu C.-J.; Yan S.-H.; Sun Y.; Yang S.-Y. | Neurology and Therapy | 0 | 0 | |
2 | 2021 | Synergistic Association between Plasma Aβ1-42and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | MING-JANG CHIU ; Yang S.-Y.; TA-FU CHEN ; CHIN-HSIEN LIN ; Yang F.-C.; Chen W.-P.; Zetterberg H.; Blennow K. | ACS Chemical Neuroscience | 9 | 6 | |
3 | 2020 | Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology | Liu H.-C.; Lin W.-C.; MING-JANG CHIU ; Lu C.-H.; Lin C.-Y.; Yang S.-Y. | PLoS ONE | 14 | 14 | |
4 | 2020 | Stability of Plasma Amyloid-β 1-40, Amyloid-β 1-42, and Total Tau Protein over Repeated Freeze/Thaw Cycles | Liu H.-C.; MING-JANG CHIU ; CHIN-HSIEN LIN ; Yang S.-Y. | Dementia and Geriatric Cognitive Disorders Extra | 15 | 16 | |
5 | 2020 | Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease – A cross-validation study | MING-JANG CHIU ; TA-FU CHEN ; Hu C.-J.; Yan S.-H.; Sun Y.; Liu B.-H.; Chang Y.-T.; Yang C.-C.; Yang S.-Y. | Nanomedicine: Nanotechnology, Biology, and Medicine | 21 | 19 | |
6 | 2020 | Composite Scores of Plasma Tau and β-Amyloids Correlate with Dementia in down Syndrome | Fang W.-Q.; WUH-LIANG HWU ; YIN-HSIU CHIEN ; Yang S.-Y.; Chieh J.-J.; Chang L.-M.; Huang A.-C.; NI-CHUNG LEE ; MING-JANG CHIU | ACS Chemical Neuroscience | 4 | 4 | |
7 | 2019 | Plasma ps129-α-synuclein is a surrogate biofluid marker of motor severity and progression in parkinson's disease | CHIN-HSIEN LIN ; Liu H.-C.; Yang S.-Y.; KAI-CHIEN YANG ; CHAU-CHUNG WU ; MING-JANG CHIU | Journal of Clinical Medicine | 20 | 17 | |
8 | 2019 | Long-Term Storage Effects on Stability of Aβ1-40, Aβ1-42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays | MING-JANG CHIU ; Lue L.-F.; Sabbagh M.N.; TA-FU CHEN ; Chen H.H.; Yang S.-Y. | Dementia and Geriatric Cognitive Disorders Extra | 15 | 13 | |
9 | 2018 | Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment | SUNG-CHUN TANG ; KAI-CHIEN YANG ; CHIH-HAO CHEN ; Yang S.-Y.; MING-JANG CHIU ; CHAU-CHUNG WU ; JIANN-SHING JENG | NeuroMolecular Medicine | 16 | 16 | |
10 | 2018 | The relation between brain amyloid deposition, cortical atrophy, and plasma biomarkers in amnesic mild cognitive impairment and Alzheimer's Disease | Fan L.-Y.; KAI-YUAN TZEN ; YA-FANG CHEN ; TA-FU CHEN ; Lai Y.-M.; RUOH-FANG YEN ; Huang Y.-Y.; Shiue C.-Y.; Yang S.-Y.; MING-JANG CHIU | Frontiers in Aging Neuroscience | 51 | 47 | |
11 | 2018 | Assay of plasma phosphorylated tau protein (threonine 181) and total tau protein in early-stage Alzheimer's disease | Yang C.-C.; MING-JANG CHIU ; TA-FU CHEN ; Chang H.-L.; Liu B.-H.; Yang S.-Y. | Journal of Alzheimer's Disease | 98 | 90 | |
12 | 2018 | Plasma biomarkers differentiate Parkinson's disease from atypical parkinsonism syndromes | CHIN-HSIEN LIN ; Yang S.-Y.; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H.; MING-JANG CHIU | Frontiers in Aging Neuroscience | 41 | 36 | |
13 | 2018 | Eight-channel AC magnetosusceptometer of magnetic nanoparticles for high-throughput and ultra-high-sensitivity immunoassay | Chieh J.-J.; Wei W.-C.; Liao S.-H.; Chen H.-H.; Lee Y.-F.; Lin F.-C.; Chiang M.-H.; MING-JANG CHIU ; Horng H.-E.; Yang S.-Y. | Sensors (Switzerland) | 16 | 13 | |
14 | 2018 | Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease | Teunissen C.E.; MING-JANG CHIU ; Yang C.-C.; Yang S.-Y.; Scheltens P.; Zetterberg H.; Blennow K. | Journal of Alzheimer's disease : JAD | 94 | 88 | |
15 | 2017 | Plasma α-synuclein predicts cognitive decline in Parkinson's disease | CHIN-HSIEN LIN ; Yang S.-Y.; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H.; MING-JANG CHIU | Journal of Neurology, Neurosurgery and Psychiatry | 113 | 99 | |
16 | 2017 | Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases | Yang S.-Y.; MING-JANG CHIU ; TA-FU CHEN ; CHIN-HSIEN LIN ; JIANN-SHING JENG ; SUNG-CHUN TANG ; Lee Y.-F.; Yang C.-C.; Liu B.-H.; Chen H.-H.; CHAU-CHUNG WU | Scientific Reports | 46 | 39 | |
17 | 2017 | Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease | Yang S.-Y.; MING-JANG CHIU ; TA-FU CHEN ; Horng H.-E. | Neurology and Therapy | 58 | 0 | |
18 | 2017 | Plasma levels of Aβ42 and Tau identified probable Alzheimer's dementia: Findings in two cohorts | Lue L.-F.; MING-JANG CHIU et al. ; Chiu M.-J.; Jing N.; Snyder N.L.; Schmitz C.; Guerra A.; Belden C.M.; TA-FU CHEN ; Yang C.-C.; Yang S.-Y.; Walker D.G.; Chen K.; Reiman E.M. | Frontiers in Aging Neuroscience | 80 | 75 | |
19 | 2016 | Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles | Yang S.-Y.; MING-JANG CHIU ; CHIN-HSIEN LIN ; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H. | Journal of Nanobiotechnology | 48 | 46 | |
20 | 2014 | Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease | MING-JANG CHIU ; YA-FANG CHEN ; TA-FU CHEN ; Yang S.-Y.; Yang F.-P.G.; Tseng T.-W.; Chieh J.-J.; Chen J.-C.R.; KAI-YUAN TZEN ; Hua M.-S.; Horng H.-E. | Human Brain Mapping | 115 | 106 | |
21 | 2014 | Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease | KAI-YUAN TZEN ; Yang S.-Y.; TA-FU CHEN ; Cheng T.-W.; Horng H.-E.; Wen H.-P.; Huang Y.-Y.; Shiue C.-Y.; MING-JANG CHIU | ACS Chemical Neuroscience | 87 | 86 | |
22 | 2013 | Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease | MING-JANG CHIU et al. ; Yang S.-Y.; Horng H.-E.; Yang C.-C.; TA-FU CHEN ; Chieh J.-J.; Chen H.-H.; Chen T.-C.; Ho C.-S.; Chang S.-F.; Liu H.C.; Hong C.-Y.; Yang H.-C. | ACS Chemical Neuroscience | 112 | 105 | |
23 | 2011 | Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer's disease in vitro | Yang C.-C.; Yang S.-Y.; Chieh J.-J.; Horng H.-E.; Hong C.-Y.; Yang H.-C.; Chen K.H.; Shih B.Y.; TA-FU CHEN ; MING-JANG CHIU | ACS Chemical Neuroscience | 99 | 93 |